IDIVE
Live / Registered — Registered (as of 14 Apr 2020)
What this means for you
Registered since 14 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79270073
- Registration number
- 6031642
- Mark type
- Stylized text
- Filed
- 19 Jul 2019
- Published for opposition
- 28 Jan 2020
- Registered
- 14 Apr 2020
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable and recorded medical software for visualization of reference data for use by patients and health care professionals; downloadable and recorded medical software for visual data capture and information management; downloadable and recorded software applications for mobile telephones for visualization of medical reference data; downloadable and recorded software applications for mobile telephones for visual data capture and information management
- Class 042 — Scientific and technological services: providing a website featuring non-downloadable medical and scientific research information in the field of pharmaceutical and clinical studies
- Class 044 — Medical, beauty and agricultural services: Providing health information
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 14 Apr 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 26 Sept 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 05 Sept 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 26 Aug 2020 — FINAL DISPOSITION PROCESSED
- 14 Jul 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 14 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 28 Jan 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2020 — PUBLISHED FOR OPPOSITION
- 08 Jan 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Dec 2019 — REFUSAL PROCESSED BY IB
- 26 Dec 2019 — ASSIGNED TO LIE
- 21 Dec 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Dec 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Dec 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED